Chemoinformaics analysis of 2-(1-HYDROXYETHYL)NAPHTHO(2,3-B)FURAN-4,9-DIONE
| Molecular Weight | 242.23 | nRot | 1 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 16 |
| Exact Molecular Weight | 242.058 | nRing | 3 |
| Solubility: LogS | -3.446 | nHRing | 1 |
| Solubility: LogP | 2.861 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 11 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 33.2559 |
| nHD | 1 | BPOL | 13.5041 |
| QED | 0.507 |
| Synth | 2.471 |
| Natural Product Likeliness | 0.654 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.137 |
| Pgp-sub | 0.002 |
| HIA | 0.045 |
| CACO-2 | -4.942 |
| MDCK | 0.000016 |
| BBB | 0.018 |
| PPB | 0.956652 |
| VDSS | 0.551 |
| FU | 0.0852749 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.398 |
| CYP2c19-sub | 0.106 |
| CYP2c9-inh | 0.59 |
| CYP2c9-sub | 0.593 |
| CYP2d6-inh | 0.632 |
| CYP2d6-sub | 0.295 |
| CYP3a4-inh | 0.185 |
| CYP3a4-sub | 0.123 |
| CL | 4.548 |
| T12 | 0.811 |
| hERG | 0.006 |
| Ames | 0.546 |
| ROA | 0.335 |
| SkinSen | 0.819 |
| Carcinogencity | 0.826 |
| EI | 0.805 |
| Respiratory | 0.661 |
| NR-Aromatase | 0.779 |
| Antiviral | Yes |
| Prediction | 0.670598 |